International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, 4-8 June 2013, Toronto

25 July 2013. Related: Conference reports, Conference index, Intl Drug Resistance Workshop Toronto 2013.

This annual meeting had developed from its previous focus on HIV drug resistance to include resistance to hepatitis C and developments in cure research.

The meeting has a diverse and interesting programme and the organisers helpfully post the programme, abstract books and links to some of the oral presentations online.

Reports in this issue of HTB include:

• Higher intracellular concentrations with tenofovir alafenamide (TAF) overcomes K65R and other key NRTI resistance in vitro
• Tentative phenotypic cut offs for dolutegravir: guidance for use with integrase resistance
• S/GSK744 and long-acting formulation indicate broadly similar resistance profile to dolutegravir
• One in five people with recent HIV infection in Spain have X4/R5 mixed tropic virus

Conference website:
http://www.informedhorizons.com/resistance2013

Abstract book:
http://www.intmedpress.com/journals/avt/abstract.cfm?id=2658&pid=88

Presentations:
http://www.informedhorizons.com/resistance2013/presentations.html